Skip to main content
PMC home page
Thorax logoLink to Thorax
. 1997 May;52(5):476–482. doi: 10.1136/thx.52.5.476

Measures for detecting systemic bioactivity with inhaled and intranasal corticosteroids

B J Lipworth, J R Seckl
PMCID: PMC1758571  PMID: 9176542

Full Text

The Full Text of this article is available as a PDF (132.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Agertoft L., Pedersen S. Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children. Respir Med. 1994 May;88(5):373–381. doi: 10.1016/0954-6111(94)90044-2. [DOI] [PubMed] [Google Scholar]
  2. Allen D. B., Mullen M., Mullen B. A meta-analysis of the effect of oral and inhaled corticosteroids on growth. J Allergy Clin Immunol. 1994 Jun;93(6):967–976. doi: 10.1016/s0091-6749(94)70043-5. [DOI] [PubMed] [Google Scholar]
  3. Balfour-Lynn L. Growth and childhood asthma. Arch Dis Child. 1986 Nov;61(11):1049–1055. doi: 10.1136/adc.61.11.1049. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Barnes N. C., Marone G., Di Maria G. U., Visser S., Utama I., Payne S. L. A comparison of fluticasone propionate, 1 mg daily, with beclomethasone dipropionate, 2 mg daily, in the treatment of severe asthma. International Study Group. Eur Respir J. 1993 Jun;6(6):877–885. [PubMed] [Google Scholar]
  5. Birkebaek N. H., Esberg G., Andersen K., Wolthers O., Hassager C. Bone and collagen turnover during treatment with inhaled dry powder budesonide and beclomethasone dipropionate. Arch Dis Child. 1995 Dec;73(6):524–527. doi: 10.1136/adc.73.6.524. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Boe J., Bakke P., Rødølen T., Skovlund E., Gulsvik A. High-dose inhaled steroids in asthmatics: moderate efficacy gain and suppression of the hypothalamic-pituitary-adrenal (HPA) axis. Research Council of the Norwegian Thoracic Society. Eur Respir J. 1994 Dec;7(12):2179–2184. doi: 10.1183/09031936.94.07122179. [DOI] [PubMed] [Google Scholar]
  7. Bootsma G. P., Dekhuijzen P. N., Festen J., Mulder P. G., Swinkels L. M., van Herwaarden C. L. Fluticasone propionate does not influence bone metabolism in contrast to beclomethasone dipropionate. Am J Respir Crit Care Med. 1996 Mar;153(3):924–930. doi: 10.1164/ajrccm.153.3.8630574. [DOI] [PubMed] [Google Scholar]
  8. Broide J., Soferman R., Kivity S., Golander A., Dickstein G., Spirer Z., Weisman Y. Low-dose adrenocorticotropin test reveals impaired adrenal function in patients taking inhaled corticosteroids. J Clin Endocrinol Metab. 1995 Apr;80(4):1243–1246. doi: 10.1210/jcem.80.4.7714095. [DOI] [PubMed] [Google Scholar]
  9. Brown P. H., Blundell G., Greening A. P., Crompton G. K. Screening for hypothalamo-pituitary-adrenal axis suppression in asthmatics taking high dose inhaled corticosteroids. Respir Med. 1991 Nov;85(6):511–516. doi: 10.1016/s0954-6111(06)80269-6. [DOI] [PubMed] [Google Scholar]
  10. Clark D. J., Clark R. A., Lipworth B. J. Adrenal suppression with inhaled budesonide and fluticasone propionate given by large volume spacer to asthmatic children. Thorax. 1996 Sep;51(9):941–943. doi: 10.1136/thx.51.9.941. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Crowley S., Hindmarsh P. C., Holownia P., Honour J. W., Brook C. G. The use of low doses of ACTH in the investigation of adrenal function in man. J Endocrinol. 1991 Sep;130(3):475–479. doi: 10.1677/joe.0.1300475. [DOI] [PubMed] [Google Scholar]
  12. Crowley S., Hindmarsh P. C., Honour J. W., Brook C. G. Reproducibility of the cortisol response to stimulation with a low dose of ACTH(1-24): the effect of basal cortisol levels and comparison of low-dose with high-dose secretory dynamics. J Endocrinol. 1993 Jan;136(1):167–172. doi: 10.1677/joe.0.1360167. [DOI] [PubMed] [Google Scholar]
  13. Crowley S., Hindmarsh P. C., Matthews D. R., Brook C. G. Growth and the growth hormone axis in prepubertal children with asthma. J Pediatr. 1995 Feb;126(2):297–303. doi: 10.1016/s0022-3476(95)70566-x. [DOI] [PubMed] [Google Scholar]
  14. Edsbäcker S., Andersson K. E., Ryrfeldt A. Nasal bioavailability and systemic effects of the glucocorticoid budesonide in man. Eur J Clin Pharmacol. 1985;29(4):477–481. doi: 10.1007/BF00613465. [DOI] [PubMed] [Google Scholar]
  15. Fabbri L., Burge P. S., Croonenborgh L., Warlies F., Weeke B., Ciaccia A., Parker C. Comparison of fluticasone propionate with beclomethasone dipropionate in moderate to severe asthma treated for one year. International Study Group. Thorax. 1993 Aug;48(8):817–823. doi: 10.1136/thx.48.8.817. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Foresi A., Pelucchi A., Gherson G., Mastropasqua B., Chiapparino A., Testi R. Once daily intranasal fluticasone propionate (200 micrograms) reduces nasal symptoms and inflammation but also attenuates the increase in bronchial responsiveness during the pollen season in allergic rhinitis. J Allergy Clin Immunol. 1996 Aug;98(2):274–282. doi: 10.1016/s0091-6749(96)70150-1. [DOI] [PubMed] [Google Scholar]
  17. Grove A., McFarlane L. C., Jackson C. M., Lipworth B. J. Effects of short-term exposure to high-dose inhaled corticosteroids on novel markers of bone metabolism. Eur J Clin Pharmacol. 1996;50(4):275–277. doi: 10.1007/s002280050107. [DOI] [PubMed] [Google Scholar]
  18. Kerstjens H. A., Postma D. S., van Doormaal J. J., van Zanten A. K., Brand P. L., Dekhuijzen P. N., Koëter G. H. Effects of short-term and long-term treatment with inhaled corticosteroids on bone metabolism in patients with airways obstruction. Dutch CNSLD Study Group. Thorax. 1994 Jul;49(7):652–656. doi: 10.1136/thx.49.7.652. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Knutsson P. U., Brönnegård M., Marcus C., Stierna P. Regulation of glucocorticoid receptor mRNA in nasal mucosa by local administration of fluticasone and budesonide. J Allergy Clin Immunol. 1996 Feb;97(2):655–661. doi: 10.1016/s0091-6749(96)70311-1. [DOI] [PubMed] [Google Scholar]
  20. Knutsson U., Stierna P., Marcus C., Carlstedt-Duke J., Carlström K., Brönnegård M. Effects of intranasal glucocorticoids on endogenous glucocorticoid peripheral and central function. J Endocrinol. 1995 Feb;144(2):301–310. doi: 10.1677/joe.0.1440301. [DOI] [PubMed] [Google Scholar]
  21. Lipworth B. J. Airway and systemic effects of inhaled corticosteroids in asthma: dose response relationship. Pulm Pharmacol. 1996 Feb;9(1):19–27. doi: 10.1006/pulp.1996.0002. [DOI] [PubMed] [Google Scholar]
  22. Lipworth B. J., Clark D. High-dose inhaled steroids in asthmatic children. Lancet. 1996 Sep 21;348(9030):820–821. doi: 10.1016/S0140-6736(05)65234-8. [DOI] [PubMed] [Google Scholar]
  23. Lipworth B. J. New perspectives on inhaled drug delivery and systemic bioactivity. Thorax. 1995 Feb;50(2):105–110. doi: 10.1136/thx.50.2.105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Lipworth B. J. Pharmacokinetics of inhaled drugs. Br J Clin Pharmacol. 1996 Dec;42(6):697–705. doi: 10.1046/j.1365-2125.1996.00493.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Lundback B., Alexander M., Day J., Hebert J., Holzer R., Van Uffelen R., Kesten S., Jones A. L. Evaluation of fluticasone propionate (500 micrograms day-1) administered either as dry powder via a Diskhaler inhaler or pressurized inhaler and compared with beclomethasone dipropionate (1000 micrograms day-1) administered by pressurized inhaler. Respir Med. 1993 Nov;87(8):609–620. doi: 10.1016/s0954-6111(05)80264-1. [DOI] [PubMed] [Google Scholar]
  26. Lönnebo A., Grahnén A., Jansson B., Brundin R. M., Ling-Andersson A., Eckernäs S. A. An assessment of the systemic effects of single and repeated doses of inhaled fluticasone propionate and inhaled budesonide in healthy volunteers. Eur J Clin Pharmacol. 1996;49(6):459–463. doi: 10.1007/BF00195931. [DOI] [PubMed] [Google Scholar]
  27. Martin A. J., Landau L. I., Phelan P. D. The effect on growth of childhood asthma. Acta Paediatr Scand. 1981 Sep;70(5):683–688. doi: 10.1111/j.1651-2227.1981.tb05768.x. [DOI] [PubMed] [Google Scholar]
  28. Martinati L. C., Bertoldo F., Gasperi E., Micelli S., Boner A. L. Effect on cortical and trabecular bone mass of different anti-inflammatory treatments in preadolescent children with chronic asthma. Am J Respir Crit Care Med. 1996 Jan;153(1):232–236. doi: 10.1164/ajrccm.153.1.8542121. [DOI] [PubMed] [Google Scholar]
  29. Pedersen S., Steffensen G., Ekman I., Tönnesson M., Borgå O. Pharmacokinetics of budesonide in children with asthma. Eur J Clin Pharmacol. 1987;31(5):579–582. doi: 10.1007/BF00606634. [DOI] [PubMed] [Google Scholar]
  30. Priftis K., Milner A. D., Conway E., Honour J. W. Adrenal function in asthma. Arch Dis Child. 1990 Aug;65(8):838–840. doi: 10.1136/adc.65.8.838. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Rasmuson S., Olsson T., Hagg E. A low dose ACTH test to assess the function of the hypothalamic-pituitary-adrenal axis. Clin Endocrinol (Oxf) 1996 Feb;44(2):151–156. doi: 10.1046/j.1365-2265.1996.600482.x. [DOI] [PubMed] [Google Scholar]
  32. Schlaghecke R., Kornely E., Santen R. T., Ridderskamp P. The effect of long-term glucocorticoid therapy on pituitary-adrenal responses to exogenous corticotropin-releasing hormone. N Engl J Med. 1992 Jan 23;326(4):226–230. doi: 10.1056/NEJM199201233260403. [DOI] [PubMed] [Google Scholar]
  33. Sorva R., Turpeinen M., Juntunen-Backman K., Karonen S. L., Sorva A. Effects of inhaled budesonide on serum markers of bone metabolism in children with asthma. J Allergy Clin Immunol. 1992 Nov;90(5):808–815. doi: 10.1016/0091-6749(92)90106-c. [DOI] [PubMed] [Google Scholar]
  34. Wolthers O. D., Pedersen S. Measures of systemic activity of inhaled glucocorticosteroids in children: a comparison of urine cortisol excretion and knemometry. Respir Med. 1995 May;89(5):347–349. doi: 10.1016/0954-6111(95)90006-3. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES